The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 16, 2020
Filed:
Dec. 20, 2019
Applicant:
Abbvie Inc., North Chicago, IL (US);
Inventors:
Sandra L. Goss, Wadsworth, IL (US);
Cheri E. Klein, Northbrook, IL (US);
Juki Wing-Keung Ng, Highland Park, IL (US);
Ahmed Salem, Libertyville, IL (US);
Assignee:
ABBVIE INC., North Chicago, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/505 (2006.01); A61K 31/513 (2006.01); A61K 31/4178 (2006.01); A61K 31/496 (2006.01); A61K 31/567 (2006.01); A61K 31/565 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/505 (2013.01); A61K 9/0053 (2013.01); A61K 31/4178 (2013.01); A61K 31/496 (2013.01); A61K 31/513 (2013.01); A61K 31/565 (2013.01); A61K 31/567 (2013.01);
Abstract
The present disclosure relates to the use of GnRH receptor antagonists used in the treatment of endometriosis or uterine fibroids. In particular, the present disclosure describes a method of treating endometriosis or uterine fibroids, where the method involves the administration of elagolix, and where the method may further involve the co-administration of rifampin or ketoconazole.